Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis

Reviews of Infectious Diseases

Volumn 10, Issue 3, 1988, Pages 551-559

  Ferguson, Berrylin J ^a   Mitchell, Thomas G ^a   Moon, Richard ^a   Camporesi, Enrico M ^a   Farmer, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; DEBRIDEMENT; FEMALE; HUMAN; HYPERBARIC OXYGEN; MALE; MUCORMYCOSIS; MULTIMODALITY CANCER THERAPY; NOSE DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; BRAIN DISEASES; COMBINED MODALITY THERAPY; DEBRIDEMENT; FEMALE; HUMAN; HYPERBARIC OXYGENATION; MALE; MIDDLE AGE; MUCORMYCOSIS; NOSE DISEASES; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0024008690     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/10.3.551     Document Type: Article

References (27)

1. Robb SM. Reactions of fungi to 10 atmospheres of pressure of oxygen. J Gen Microbiol 1966;45:17-29
2. Ferguson B, Farmer J, Hudson W, McCarthy K Jr. Tissue effects of hyperbaric oxygen in patients with rhinocerebral mucormycosis [abstract]. Lab Invest 1986;54:20A
3. Sheffield PJ. Tissue oxygen measurements with respect to soft-tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Review 1985;6:18-46
4. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980;90: 737-47
5. Nathan MD, Keller AP Jr, Lerner CJ, Davis JC. Entomophthorales infection of the maxillofacial region. Laryngoscope 1982;92:767-9
6. Scholer HJ, Muller E, Schipper MAA. Mucorales. In: Howard DH, ed. Fungi pathogenic for humans and animals. Part A. New York: Marcel Dekker, 1983:9-59
7. Brennan RO, Crain BJ, Proctor AM, Durack DT. Cunninghamella: A newly recognized cause of rhinocerebral mucormycosis. Am J Clin Pathol 1983;80:98-102
8. Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA.A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980;142:915-22
9. Moon RE, Camporesi EM, Shelton DL. Prediction of arterial Po2 during hyperbaric treatment. In: Bove AA, Bachrach AJ, Greenbaum LJ, eds. Proceedings of the IX International Symposium on Underwater and Hyperbaric Physiology. Bethesda, Md: Undersea and Hyperbaric Medical Society, 1987:1127-31
10. Hohn DC. Oxygen and leukocyte microbial killing. In: Davis SC, Hunt TK, eds. Hyperbaric oxygen therapy. Bethesda, Md: Undersea and Hyperbaric Medical Society, 1977:101-10
11. Hill GB, Osterhout S, Willett HP. Clostridium. In: Joklik WK, Willett HP, Amos DB, eds. Zinsser microbiology. 18th ed. Norwalk, Conn: Appleton-Century-Crofts, 1984: 697-719
12. Bakker DJ. The use of hyperbaric oxygen in the treatment of certain infectious diseases especially gas gangrene and acute dermal gangrene. Wageningen: Drukkerij Veenman BV, 1984
13. Davis JC, Heckman JD, DeLee JC, Buck wold FJ. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg 1986;68-A:1210-7
14. Morrey BF, Dunn JM, Heimbach RD, Davis J. Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop 1979; 144:121-7
15. Farmer JC Jr, Shelton DL, Angelillo JD, Bennett PD, Hudson WR. Treatment of radiation-induced tissue injury by hyperbaric oxygen. Ann Otol Rhinol Laryngol 1978;87: 707-15
16. Pittinger CB. Hyperbaric oxygenation. Springfield, 111: Charles C. Thomas, 1966:10-5
17. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977;103:600-4
18. Meyers BR, Wormser G, Hirschman SZ, Blitzer A. Rhinocerebral mucormycosis: Premortem diagnosis and therapy. Arch Intern Med 1979;139:557-60
19. Abramson E, Wilson D, Arky RA. Rhinocerebral phycomycosis in association with diabetic ketoacidosis: Report of two cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med 1967;66:735-42
20. Meyer RD, Armstrong D. Mucormycosis -changing status.CRC Crit Rev Clin Lab Sei 1973;4:421-51
21. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis (UCLA conference). Ann Intern Med 1980;93:93-108
22. Schwartz JN, Donnelly EH, Klintworth GK. Ocular and orbital phycomycosis. Surv Ophthalmol 1977;22:3-28
23. Abedi E, Sismanis A, Choi K, Pastore P. Twenty-five years’experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984;94:1060-2
24. Kline MW. Mucormycosis in children: Review of the literature and report of cases. Pediatr Infect Dis 1985;4:672-6
25. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-48
26. Best M, Obstbaum SA, Friedman B, Strobos RJ. Survival in orbital phycomycosis. Am J Ophthalmol 1971;71:1078-80
27. Bullock JD, Jampol LM, Fezza AJ. Two cases of orbital phycomycosis with recovery. Am J Ophthalmol 1974;78: 811-5